This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Apter JT, Kushner SF, Woolfolk RL (1994) Bupropion/Nortriptyline combination for refractory depression. Ann Clin Psychiatry 6: 255–258
Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51: 248–251
Bakish D (1994) Potentiation of fluoxetine by buspirone and trazodone in refractory depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD (eds) Refractory depression: Current strategies and future directions. Wiley, New York, pp. 143–145
Bauer M, Linden M (1993) Die Kombination verschiedener Antidepressiva in der Behandlung therapieresistenter Depressionen. Nervenarzt 64: 343-347
Berlanga C, Ortega-Soto HA (1995) A 3-year follow-up of a group of treatment-resistant depressed patients with a MAOI/tricyclic combination. J Affect Disorders 34: 187–192
Blecourt CV de, Gudde H (1992) Surplus value of combining antidepressants in refractory depression. Second International Conference on Refractory Depression, 24. - 26.6.1992, Amsterdam (Abstract)
Blier P, Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15: 217–222
Boyer WF, Feighner JP (1991) Pharmacokinetics and drug interactions. In: Feighner JP, Boyer WF (eds) Selective serotonin re-uptake inhibitors. Wiley, New York, pp. 81–58
Ebert D, Albert R, May A, Stosiek I, Kaschka W (1995) Combined SSRI–RIMA treatment in refractory depression–safety data and efficacy. Psychopharmacology 119: 342–344
Fava M, Rosenbaum JF, McGrath PJ, Stewart JW, Amsterdam JD, Quitkin FM (1994) Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: A douple-blind, controlled study. Am J Psychiatry 151: 1372-1374
Feighner JP, Boyer WF, Tyler DL, Neborsky R (199o) Adverse consequences of fluoxetineMAOI combination therapy. J Clin Psychiatry 51: 222–225
Heimchen H (199o) Gestuftes Vorgehen bei Resistenz gegen Antidepressiva-Therapie. In: Möller HJ (ed) Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin, Heidelberg, S. 237–250
Jacobsen FM (1990) Low-dose trazodone as a hypnotic in patients treated with MAOI and other psychotropics: A pilot study. J Clin Psychiatry 51: 298–302
Jacobsen FM (1991) Possible augmentation of antidepressant response by buspirone. J Clin Psychiatry 52: 217–220
Joffe RT, Bakisch D (1994) Combined SSRI-moclobemide treatment of psychiatric illness. J Clin Psychiatry 55: 24–25
Joffe RT, Schuller DR (1993) An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J Clin Psychiatry 54: 269–271
Kuhs H (1995) Stufen in der Behandlungsresistenz bei depressiven Störungen, definiert nach somatotherapeutischen Verfahren. Nervenarzt 66: 561–567
Lauritzen L Clemmensen L, Klysner R, Loldrup D, Lunde M, Schaumburg E, Waarst S, Bech P (1992) Combined treatment with imipramine and mianserine: A controlled pilot study. Pharmacopsychiatry 25: 182–186
Linden M, Helmchen H, Mackert A, Müller-Oerlinghausen B (1994) Structure and feasibility of a standardized stepwise drug treatment regimen (SSTR) for depressed inpatients. Pharmacopsychiatry 27(Suppl.): 51–53
Möller HJ (1991) Therapieresistenz auf Antidepressiva: Risikofaktoren and Behandlungsmöglichkeiten. Nervenarzt 62: 658–669
Nelson JC (1993) Combined treatment strategies in Psychiatry. J Clin Psychiatry 54: 42–49
Nelson JC, Mazure CM, Bowers MB, Jatlow PI (1991) A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 48: 303–307
Nierenberg M (1994) The treatment of severe depression: Is there an efficacy gap between SSRI and TCA antidepressant generations? J Clin Psychiatry 55(9): 55–59
Nierenberg AA, Adler LA, Peselow E, Zornberg G, Rosenthal M (1994) Trazodone for antidepressant-associated insomnia. Am J Psychiatry 151: 1069–1072
Nierenberg AA, Cole JO, Glass L (1992) Possible trazodone potentiation of fluoxetine: A cases series. J Clin Psychiatry 53: 83–85
Nierenberg M, Keck PE (1989) Management of monoamine oxidase inhibitor-associated insomnia with trazodone. J Clin Psychopharmacol 9: 42–45
O’Brien S, McKeon P, O’Regan M (1993) The efficacy and tolerability of combined antidepressant treatment in different depressive subgroups. Br J Psychiatry 162: 363–368
Rosenthal JS, Kaswan MJ, Hemlock C, Winston A (1991) Fluoxetine enhancement of heterocyclic antidepressants. In: Amsterdam JD (ed) Refractory depression. Raven, New York, pp. 105–108
Saria A, Neumann R, Humpel C, Lieder F, Dosser G, Oberbauer H (1991) Plasma levels of amitriptyline during treatment of depression: Influence of combined treatment with dibenzepine. In: Racagni G, Brunello N, Fukuda T (eds) Biological Psychiatry, Volume 1, Elsevier, Amsterdam, pp. 365–367
Schmauss M, Kampfhammer HP, Meyr P, Hoff P (1986) Combined MAO-inhibitor and tri-(tetra-) cyclic antidepressant treatment in therapy resistant depression: A retrospective study. Pharmacopsychiatry 19: 251–252
Seth R, Jennings AL, Bindman J, Philips J, Bergmann K (1992) Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression. Br J Psychiatry 161: 562–565
Sternbach H (1991) The serotonin syndrome. Am J Psychiatry 148: 705–713
Tanum LH (1994) Combination treatment with antidepressants in refractory depression. Int Clin Psychopharmacology 9: 37–40
Taylor D (1995) Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination: Interactions and therapeutic uses. Br J Psychiatry 167: 575-580
Wailnöfer A, Guentert TW, Eckernäs SA, Dingemanse J (1995) Moclobemide and fluvoxamine co-administration: A prospective study in healthy volunteers to investigate the potential development of the „serotonin syndrome“. Human Psychopharmacol 1o: 25–31
Weilburg JB, Rosenbaum JF, Biederman J, Sachs GS, Pollack MH, Kelly K (1989) Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: A preliminary report. J Clin Psychiatry 50: 447–449
White K, Pistole T, Boyd JL (1980) Combined monamine oxidase inhibitor-tricyclic antidepressant treatment: A pilot study. Am J Psychiatry 137: 1422–1425
White K, Simpson G (1986) Combined MAOI-tricyclic antidepressant treatment: A reevaluation. J Clin Psychopharmacol 1: 264–282
Zajecka JM, Jeffries H, Fawcett J (1995) The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: A retrospective analysis. J Clin Psychiatry 56: 338–343
Zimmer B, Daly F, Benjamin L (1984) More on combination antidepressant therapy. Arch Gen Psychiatry 41: 527–528
Zimmer R, Gieschke R, Fischbach R, Gasic S (1990) Interaction studies with moclobemide. Acta Psychiatr Scand 360: 84–86
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Mavrogiorgou, P., Juckel, G., Hellweg, R. (1997). Antidepressiva-Kombinationen bei therapieresistenten Depressionen. In: Bauer, M., Berghöfer, A. (eds) Therapieresistente Depressionen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10500-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-10500-9_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61675-7
Online ISBN: 978-3-662-10500-9
eBook Packages: Springer Book Archive